CBD /

 

Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
ABSCH-IRCC-IN-207611-2   |   PDF   |   Print   |  
| 
|  Close
published: 16 Aug 2016 last updated: 22 Nov 2016
General Information
India
ABSCH-IRCC-IN-207611-2

As per the email communication of CBD Secretariat Dated 17th August 2016 regarding missing information on an " issuing Authority ", the record has been updated by incorporating the information about issuing Authority.

- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Email: secretary@nbaindia.org, chairman@nba.nic.in, secretary@nba.nic.in,
Website: http://www.nbaindia.org,
ABSCH-CNA-IN-202013-2
Details of the permit or its equivalent
India/NBA/Appl/9/683
Application in Form-III seeking approval for the invention "Anti-bacterial and Anti-fungal drugs preparation and their medicinal properties and formulation of development of 10 Plus Product" for obtaining IP Rights in India and United Kingdom.
01 Jun 2015
Prior Informed Consent (PIC) Information
Yes
Confidential information
Confidential information
Mutually Agreed Terms (MAT) Information
Yes

1. The user shall notify the NBA on the grant of IPR within 30 days thereof. 

2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 

3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.

4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.  


Subject-matter or genetic resource(s)
Confidential information
We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Observing System Data and Information System (EOSDIS).


Information on the utilization of the genetic resource(s)
Confidential information
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument.   

Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-207611-2
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
22 Nov 2016 07:08
on 22 Nov 2016 07:08

As per the email communication of CBD Secretariat Dated 17th August 2016 regarding missing information on an " issuing Authority ", the record has been updated by incorporating the informa

 ...more

As per the email communication of CBD Secretariat Dated 17th August 2016 regarding missing information on an " issuing Authority ", the record has been updated by incorporating the information about issuing Authority.

 ...less
ABSCH-IRCC-IN-207611-1
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
16 Aug 2016 11:40
on 16 Aug 2016 11:40
...less

Quick links

About the ABS Clearing-House About the Nagoya Protocol
Search records Country profiles Submit records

Need help?

Contact us Introduction to the ABSCH Getting started Information sharing obligations How monitoring utilization works Interoperability Offline common formats

ABS Clearing-House